Clinical Benefit of Sacubitril/Valsartan for Hypertensive Patients in Daily Practice and Predictors of Its Antihypertensive Effect-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Benefit of Sacubitril/Valsartan for Hypertensive Patients in Daily Practice and Predictors of Its Antihypertensive Effect

Published:2024-07-10 Issue:7 Volume:6 Page:248-254
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Horio Takeshi¹,Iwashima Yoshio²,Yoshiyama Minoru³,Fukuda Daiju⁴,Hasegawa Takamasa⁵,Fujimoto Kohei¹

Affiliation:

1. Department of Cardiovascular Medicine, Ishikiriseiki Hospital

2. Department of Internal Medicine, Kansai Medical University Kori Hospital

3. Department of Internal Medicine, Daito Central Hospital

4. Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine

5. Department of Diabetes and Metabolism, Ishikiriseiki Hospital

Publisher

Japanese Circulation Society

Link

https://www.jstage.jst.go.jp/article/circrep/6/7/6_CR-24-0017/_pdf

Reference23 articles.

1. 1. Bavishi C, Messerli FH, Kadosh B, Ruilope LM, Kario K. Role of neprilysin inhibitor combinations in hypertension: Insights from hypertension and heart failure trials. Eur Heart J 2015; 36: 1967–1973.

2. 2. Lin DS, Wang TD, Buranakitjaroen P, Chen CH, Cheng HM, Chia YC, et al. Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe. J Clin Hypertens 2021; 23: 556–567.

3. 3. Yamamoto K, Rakugi H. Angiotensin receptor-neprilysin inhibitors: Comprehensive review and implications in hypertension treatment. Hypertens Res 2021; 44: 1239–1250.

4. 4. Tsutsui H, Momomura SI, Saito Y, Ito H, Yamamoto K, Sakata Y, et al. Long-term treatment with sacubitril/valsartan in Japanese patients with chronic heart failure and reduced ejection fraction: Open-label extension of the PARALLEL-HF Study. Circ J 2024; 88: 43–52.

5. 5. Tsutsui H, Momomura SI, Saito Y, Ito H, Yamamoto K, Sakata Y, et al. Efficacy and safety of sacubitril/valsartan in Japanese patients with heart failure according to baseline systolic blood pressure: Results from a subgroup analysis of the PARALLEL-HF Study. Circ J 2024; 88: 53–61.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3